373 related articles for article (PubMed ID: 23811849)
21. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1.
Chen X; Cheng F; Liu Y; Zhang L; Song L; Cai X; You T; Fan X; Wang D; Gong A; Zhu H
EBioMedicine; 2019 Feb; 40():135-150. PubMed ID: 30679086
[TBL] [Abstract][Full Text] [Related]
23. High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway.
Han L; Zhang M; Wang M; Jia J; Zhao M; Fan Y; Li X
PLoS One; 2016; 11(4):e0154187. PubMed ID: 27100831
[TBL] [Abstract][Full Text] [Related]
24. Toll-Like Receptor 4 Signaling in High Mobility Group Box-1 Protein 1 Mediated the Suppression of Regulatory T-Cells.
Luo C; Liu H; Wang H; Wang J
Med Sci Monit; 2017 Jan; 23():300-308. PubMed ID: 28096525
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Hodge JW; Garnett CT; Farsaci B; Palena C; Tsang KY; Ferrone S; Gameiro SR
Int J Cancer; 2013 Aug; 133(3):624-36. PubMed ID: 23364915
[TBL] [Abstract][Full Text] [Related]
26. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
28. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
29. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis.
Lin Q; Yang XP; Fang D; Ren X; Zhou H; Fang J; Liu X; Zhou S; Wen F; Yao X; Wang JM; Su SB
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1024-32. PubMed ID: 21372296
[TBL] [Abstract][Full Text] [Related]
30. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
[TBL] [Abstract][Full Text] [Related]
31. Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines.
Hannani D; Locher C; Yamazaki T; Colin-Minard V; Vetizou M; Aymeric L; Viaud S; Sanchez D; Smyth MJ; Bruhns P; Kroemer G; Zitvogel L
Cell Death Differ; 2014 Jan; 21(1):50-8. PubMed ID: 23744294
[TBL] [Abstract][Full Text] [Related]
32. HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway.
Cheng Y; Wang D; Wang B; Li H; Xiong J; Xu S; Chen Q; Tao K; Yang X; Zhu Y; He S
Mol Biol Cell; 2017 Jan; 28(1):201-209. PubMed ID: 27807045
[TBL] [Abstract][Full Text] [Related]
33. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM
J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254
[TBL] [Abstract][Full Text] [Related]
34. Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation.
Kaisho T; Hoshino K; Iwabe T; Takeuchi O; Yasui T; Akira S
Int Immunol; 2002 Jul; 14(7):695-700. PubMed ID: 12096028
[TBL] [Abstract][Full Text] [Related]
35. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
36. Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
[TBL] [Abstract][Full Text] [Related]
37. HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells.
Wang C; Fei G; Liu Z; Li Q; Xu Z; Ren T
Cancer Biol Ther; 2012 Jul; 13(9):727-36. PubMed ID: 22617774
[TBL] [Abstract][Full Text] [Related]
38. High-mobility group box-1-Toll-Like receptor 4 axis mediates the recruitment of endothelial progenitor cells in alkali-induced corneal neovascularization.
Yang S; Yang TS; Wang F; Su SB
Int Immunopharmacol; 2015 Sep; 28(1):450-8. PubMed ID: 26202806
[TBL] [Abstract][Full Text] [Related]
39. Regulatory Effects of Toll-like Receptor 4 Knockout on CD4
Ren Y; Wang R; Jiang L; Wang X; Feng Z; He J; He X; Du G
Ann Clin Lab Sci; 2020 Nov; 50(6):761-768. PubMed ID: 33334791
[TBL] [Abstract][Full Text] [Related]
40. β-defensin-3 negatively regulates TLR4-HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells.
Gupta P; Ghosh S; Nagarajan A; Mehta VS; Sen E
Cell Signal; 2013 Mar; 25(3):682-9. PubMed ID: 23220408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
